Cell Line Isolation and Design

Comprehensive Biotechnology, Second Edition

Volumn 1, Issue , 2011, Pages 169-178

  Munro, T P ^a   Pilbrough, W ^a   Hughes, B S ^a   Gray, P P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Automation; Biopharmaceuticals; Cell line development; Cell line engineering; Chinese hamster ovary cells; Clone selection; Monoclonal antibodies

Indexed keywords

EID: 85012848864     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00024-6     Document Type: Chapter

References (23)

1. Amanullah A., Otero J.M., Mikola M., et al. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures. Biotechnology and Bioengineering 2010, 106:57-67.
2. Barnes L.M., Bentley C.M., Moy N., Dickson A.J. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells. Biotechnology and Bioengineering 2007, 96:337-348.
3. Brezinsky S.C., Chiang G.G., Szilvasi A., et al. A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. Journal of Immunological Methods 2003, 277:141-155.
4. Browne S.M., Al-Rubeai M. Selection methods for high-producing mammalian cell lines. Trends in Biotechnology 2007, 25:425-432.
5. Carroll S., Al-Rubeai M. The selection of high-producing cell lines using flow cytometry and cell sorting. Expert Opinion on Biological Therapy 2004, 4:1821-1829.
6. Chu C., Lugovtsev V., Golding H., et al. Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14802-14807.
7. Cost G.J., Freyvert Y., Vafiadis A., et al. BAK and BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells. Biotechnology and Bioengineering 2010, 105:330-340.
8. De Jesus M.J., Girard P., Bourgeois M., et al. TubeSpin satellites: A fast track approach for process development with animal cells using shaking technology. Biochemical Engineering Journal 2004, 17:217-223.
9. Hartman T.E., Sar N., Genereux K., et al. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies. Biotechnology and Bioengineering 2007, 96:294-306.
10. Jaluria P., Betenbaugh M., Konstantopoulos K., Shiloach J. Enhancement of cell proliferation in various mammalian cell lines by gene insertion of a cyclin-dependent kinase homolog. BMC Biotechnology 2007, 7:71.
11. Kanda Y., Yamane-Ohnuki N., Sakai N., et al. Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC. Biotechnology and Bioengineering 2006, 94:680-688.
12. Kennard M.L., Goosney D.L., Monteith D., et al. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology. Biotechnology and Bioengineering 2009, 104:526-539.
13. Kim H., Laudemann J., Stevens J., WU M. Expression vector engineering for recombinant protein production. Cell Line Development 2009, 6:97-108.
14. Kramer O., Klausing S., Noll T. Methods in mammalian cell line engineering: From random mutagenesis to sequence-specific approaches. Applied Microbiology and Biotechnology 2010, 88:425-436.
15. Kwaks T.H., Otte A.P. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends in Biotechnology 2006, 24:137-142.
16. Lim Y., Wong N.S., Lee Y.Y., et al. Engineering mammalian cells in bioprocessing - current achievements and future perspectives. Biotechnology and Applied Biochemistry 2010, 55:175-189.
17. Lindgren K., Salmen A., Lundgren M., et al. Automation of cell line development. Cytotechnology 2009, 59:1-10.
18. Mattanovich D., Borth N. Applications of cell sorting in biotechnology. Microbial Cell Factories 2006, 5:12.
19. Oumard A., Qiao J., Jostock T., et al. Recommended method for chromosome exploitation: RMCE-based cassette-exchange systems in animal cell biotechnology. Cytotechnology 2006, 50:93-108.
20. Pilbrough W., Munro T.P., Gray P. Intraclonal protein expression heterogeneity in recombinant CHO cells. PLoS One 2009, 4:e8432.
21. Sleiman R.J., Gray P.P., Sunstrom N.A. Splitting the difference: When near enough is not close enough. Cytometry Part A 2006, 69A:426.
22. Walsh G. Biopharmaceutical benchmarks 2010. Nature Biotechnology 2010, 28:917-924.
23. Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 2004, 22:1393-1398.